This webinar addresses common pitfalls in FDA cybersecurity submissions for medical devices and provides actionable strategies to ensure successful approval. It delves into the specific requirements and expectations of the FDA, helping manufacturers navigate the complex regulatory landscape. Attendees will gain a clearer understanding of what constitutes a robust submission and how to avoid critical errors that often lead to rejections. By focusing on practical application and regulatory compliance, the session aims to demystify the submission process.
The discussion covers key areas where submissions frequently fall short, such as inadequate risk management, insufficient documentation, and a lack of alignment with FDA guidelines. It highlights the importance of proactive cybersecurity measures, thorough vulnerability assessments, and comprehensive post-market surveillance plans. The webinar emphasizes that a successful submission is not just about meeting minimum requirements but about demonstrating a deep commitment to patient safety and data integrity through a well-articulated and evidence-based cybersecurity posture.
The presentation will also touch upon the evolving nature of FDA regulations, including emerging expectations around software bill of materials (SBOM) and vulnerability exploitability exchange (VEX). It will provide guidance on integrating these components into submission packets and leveraging frameworks like ISO 14971 and IEC 62304 to strengthen the overall cybersecurity argument. The goal is to equip medical device manufacturers with the knowledge and tools necessary to achieve timely and successful FDA approvals for their cybersecurity submissions.
30-minute strategy session. No cost, no commitment - just answers from people who've shipped 275+ devices supported.
